Medical Trials
How vitamin B3 could help fight cancer
Scientists from the University of Minnesota have found a new way to boost the body’s natural defenses against cancer.
Immunotherapy Could Replace Surgery for Certain Types of Cancer, New Study Finds
Results from a groundbreaking clinical trial could soon change the way certain types of cancers are treated.
New genetic code may be the key in understanding origins of ovarian cancer, new treatment options
ICHMOND, Va. (WRIC) — A group of scientists at Virginia Commonwealth University (VCU) may have the key to discovering cancer’s origins within the body, as well as insights into new treatment strategies for ovarian cancer.
Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients
Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment.
The Targeted Pulse: Discover the FDAÕs Holiday Moves For Solid Tumors, Gastric, and GEJ Cancers
The subcutaneous formulation of nivolumab (Opdivo Qvantig) received FDA approval for all previously approved adult solid tumor indications as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib (Cabometyx). Data from the phase 3 CheckMate-67T study (NCT04810078) provided support for this approval. In the trial, subcutaneous nivolumab was compared with its intravenous formulation.
What turns breast cancer cells aggressive? Chinese team may have found the key
A team of Chinese scientists has uncovered a key mechanism behind how breast cancer cells weaponise the amino acid arginine to evade the immune system and multiply.
How to prime tumors to be defeated by cancer immunotherapy
Experts have thought that immune cells had to be inside of tumors for one type of immunotherapy, known as checkpoint inhibitors, to work.
Scientists develop powerful blood test method to detect and track cancer
A new study has revealed a promising method that could one day allow doctors to detect and monitor cancer using only blood tests.
This AI is creating cancer-killing molecules
The hunt for cancer-combatting antibodies normally relies upon human lab scientists combing through vast amounts of data. LabGenius’ automated AI robotic system has disrupted that process.
Cheap diabetes drug taken by millions of Britons could protect against deadly cancer
A diabetes drug which costs just 35p per pill could help prevent an aggressive form of blood cancer, according to University of Cambridge researchers.
Unique Stanford Medicine-designed AI predicts cancer prognoses, responses to treatment
A new artificial intelligence tool developed at Stanford Medicine combines data from medical images with text to predict cancer prognoses and treatment responses.
Reprogramming cancer cells to treat an aggressive type of leukemia
A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.
